All lobbying filings

FORBES-TATE

Lobbying for CSL BEHRING · Biopharmaceutical Company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 16, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.

Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.